ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04380	Osteoclast differentiation	10/95	134/7206	9.32105238189e-06
ko04145	Phagosome	10/95	162/7206	4.87754102789e-05
ko05150	Staphylococcus aureus infection	5/95	36/7206	9.77403022781e-05
ko04666	Fc gamma R-mediated phagocytosis	8/95	122/7206	0.000190496278167
ko04660	T cell receptor signaling pathway	8/95	124/7206	0.000213160594625
ko05140	Leishmaniasis	6/95	75/7206	0.000433685411793
ko04670	Leukocyte transendothelial migration	8/95	151/7206	0.000803939026885
ko04668	TNF signaling pathway	7/95	120/7206	0.000981310742278
ko04630	Jak-STAT signaling pathway	7/95	132/7206	0.00171067502735
ko05152	Tuberculosis	8/95	187/7206	0.00313534023824
ko04060	Cytokine-cytokine receptor interaction	8/95	191/7206	0.00356941024149
ko04142	Lysosome	7/95	151/7206	0.00365732166091
ko04610	Complement and coagulation cascades	5/95	79/7206	0.00374295022688
ko00601	Glycosphingolipid biosynthesis - lacto and neolacto series	3/95	28/7206	0.00572740929724
ko05323	Rheumatoid arthritis	5/95	89/7206	0.00621921891361
ko04650	Natural killer cell mediated cytotoxicity	5/95	97/7206	0.00889461455744
ko05132	Salmonella infection	5/95	98/7206	0.00927718036857
ko05130	Pathogenic Escherichia coli infection	4/95	77/7206	0.0184474398897
ko04664	Fc epsilon RI signaling pathway	4/95	77/7206	0.0184474398897
ko04611	Platelet activation	6/95	163/7206	0.0203159661605
ko05144	Malaria	3/95	45/7206	0.0211279084004
ko05131	Shigellosis	4/95	82/7206	0.0226925381853
ko00660	C5-Branched dibasic acid metabolism	1/95	2/7206	0.0261949185303
ko04662	B cell receptor signaling pathway	4/95	88/7206	0.0285154194397
ko04217	Necroptosis	6/95	178/7206	0.0297197072639
ko05321	Inflammatory bowel disease (IBD)	3/95	56/7206	0.0372332159286